Survey: Cannabis Use by Patients with Multiple Sclerosis Associated with Reductions in Need for Prescription Medicines

In a number of countries, like the UK and Canada, a marijuana plant-derived oral extract drug, Sativex, is approved for the treatment of MS-related spasticity, which in turn is reducing the need for prescription meds. Although it is still not approved in the United States, this finding is consistent with a U.S. study that found thatContinue reading “Survey: Cannabis Use by Patients with Multiple Sclerosis Associated with Reductions in Need for Prescription Medicines”